<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>GoCART | Logic-Gated CAR-T Therapies</title>

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">

  <style>
    :root {
      --primary: #5b3b6e;
      --accent: #f0b429;
      --dark: #1f1f1f;
      --muted: #6b6b6b;
      --bg: #ffffff;
    }

    * {
      box-sizing: border-box;
      margin: 0;
      padding: 0;
    }

    body {
      font-family: 'Inter', sans-serif;
      color: var(--dark);
      background: var(--bg);
      line-height: 1.6;
    }

    header {
      padding: 4rem 2rem;
      border-bottom: 1px solid #eee;
    }

    .container {
      max-width: 1100px;
      margin: 0 auto;
      padding: 0 2rem;
    }

    h1 {
      font-size: 2.4rem;
      font-weight: 700;
      color: var(--primary);
      margin-bottom: 1rem;
    }

    h2 {
      font-size: 1.6rem;
      font-weight: 600;
      color: var(--primary);
      margin-bottom: 1rem;
    }

    h3 {
      font-size: 1.1rem;
      font-weight: 600;
      margin-bottom: 0.5rem;
    }

    p {
      margin-bottom: 1rem;
      color: var(--dark);
    }

    .subtle {
      color: var(--muted);
      font-size: 0.95rem;
    }

    nav {
      border-bottom: 1px solid #eee;
    }

    nav ul {
      display: flex;
      gap: 2rem;
      list-style: none;
      padding: 1rem 2rem;
      max-width: 1100px;
      margin: 0 auto;
    }

    nav a {
      text-decoration: none;
      color: var(--dark);
      font-weight: 500;
    }

    section {
      padding: 4rem 0;
    }

    .grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
      gap: 2rem;
    }

    .card {
      border: 1px solid #eee;
      padding: 1.5rem;
    }

    ul {
      padding-left: 1.2rem;
    }

    li {
      margin-bottom: 0.6rem;
    }

    footer {
      border-top: 1px solid #eee;
      padding: 3rem 2rem;
      text-align: center;
      color: var(--muted);
      font-size: 0.9rem;
    }
  </style>
</head>

<body>

<header>
  <div class="container">
    <h1>GoCART</h1>
    <p class="subtle">
      Logic-gated CAR-T cell therapies designed to enable safe targeting beyond blood cancers.
    </p>
  </div>
</header>

<nav>
  <ul>
    <li><a href="#problem">Problem</a></li>
    <li><a href="#solution">Technology</a></li>
    <li><a href="#desci">DeSci Model</a></li>
    <li><a href="#team">Team</a></li>
    <li><a href="#roadmap">Roadmap</a></li>
  </ul>
</nav>

<main class="container">

<section id="problem">
  <h2>The Problem</h2>
  <p>
    Approximately 70% of cancers are not addressable with current targeted therapies.
    While CAR-T therapies have transformed hematological oncology, their application to
    solid tumors is limited by the absence of tumor-exclusive antigens.
  </p>
  <p>
    Single-antigen CAR-T designs activate in the presence of low-level antigen expression
    on healthy tissue, leading to off-tumor toxicity and an industry-wide development bottleneck.
  </p>
</section>

<section id="solution">
  <h2>GoCART Recognition Dimer Platform</h2>
  <div class="grid">
    <div class="card">
      <h3>True AND-Gate Logic</h3>
      <p>
        GoCART employs a recognition dimer architecture that requires simultaneous engagement
        of two antigens on the same cell to trigger T-cell activation.
      </p>
    </div>
    <div class="card">
      <h3>High Sensitivity Without Compromise</h3>
      <p>
        Unlike existing Boolean CAR designs, the platform preserves high-affinity binding
        while enforcing strict spatial coincidence, enabling physiological antigen detection.
      </p>
    </div>
    <div class="card">
      <h3>Modular and Scalable</h3>
      <p>
        Binder modules are tunable and interchangeable, allowing rapid extension to new
        antigen pairs and disease indications.
      </p>
    </div>
  </div>
</section>

<section id="desci">
  <h2>Decentralized Science Model</h2>
  <p>
    GoCART integrates a token-governed research structure using legally binding Sponsored
    Research Agreements to coordinate funding, IP ownership, and community participation.
  </p>
  <ul>
    <li>Token-based governance of intellectual property</li>
    <li>Transparent allocation of research capital</li>
    <li>Open collaboration on non-sensitive scientific outputs</li>
  </ul>
</section>

<section id="team">
  <h2>Leadership</h2>
  <div class="grid">
    <div class="card">
      <h3>Henry Erdlei, MD</h3>
      <p class="subtle">Chief Executive Officer</p>
      <p>
        Background in translational tumor immunology with medical training at Charité
        and doctoral research at the Max Delbrück Center.
      </p>
    </div>
    <div class="card">
      <h3>Arailym Myrzagaliyeva</h3>
      <p class="subtle">Chief Technology Officer</p>
      <p>
        Experience in synthetic biology, molecular biotechnology, and global health
        initiatives, including leadership roles in academic-industry partnerships.
      </p>
    </div>
    <div class="card">
      <h3>Chase Blakeley</h3>
      <p class="subtle">Chief Operating Officer</p>
      <p>
        Oversees operational execution, funding strategy, and partnerships with prior
        experience at Oracle and Tesla.
      </p>
    </div>
  </div>
</section>

<section id="roadmap">
  <h2>Development Roadmap</h2>
  <ul>
    <li><strong>2025:</strong> In-vitro proof-of-concept and binder validation</li>
    <li><strong>2026:</strong> In-vivo preclinical studies and patent filings</li>
    <li><strong>2027+:</strong> GMP manufacturing preparation and IND-enabling studies</li>
  </ul>
</section>

</main>

<footer>
  <p>
    GoCART is developing next-generation CAR-T platforms for applications beyond blood cancers.
  </p>
  <p>
    Contact: henry.erdlei@charite.de
  </p>
</footer>

</body>
</html>
